Balaxi Pharmaceuticals consolidated net profit rises 19.07% in the September 2021 quarter
Sales rise 16.41% to Rs 70.23 crore
Net profit of Balaxi Pharmaceuticals rose 19.07% to Rs 12.05 crore in the quarter ended September 2021 as against Rs 10.12 crore during the previous quarter ended September 2020. Sales rose 16.41% to Rs 70.23 crore in the quarter ended September 2021 as against Rs 60.33 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales70.2360.33 16 OPM %19.9817.07 -PBDT14.1511.88 19 PBT14.0311.81 19 NP12.0510.12 19Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content